Overview

Intranasal Oxytocin in Antiosocial Personality Disorder and Psychopathy

Status:
Completed
Trial end date:
2021-12-01
Target enrollment:
Participant gender:
Summary
A pharmacoimaging study of oxytcoin in antisocial personality disorder and psychopathy
Phase:
N/A
Details
Lead Sponsor:
King's College London
Collaborator:
Father Flanagan's Boys' Home
Treatments:
Oxytocin